Definium Therapeutics, Inc. (DFTX) Institutional Ownership & Insider Trading
358 institutions reported holding Definium Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 14 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
DFTXDefinium Therapeutics, Inc.Follow DFTX — free
—
Price chart with a free account
- Market cap
- 4.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters358 institutions held 84.1% of the shares. Across filers that reported both quarters, shares held changed +43.5%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 358 | 113 | +43.5% | 109 | 132 | 61 | 26 |
| Mar 26 | 245 | 78 | — | — | — | — | — |
| Dec 25 | 7 | 11 | — | 0 | 7 | 0 | 0 |
Definium Therapeutics, Inc. — questions
- Who owns Definium Therapeutics, Inc. stock?
- 358 institutions reported Definium Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.4%), Avoro Capital Advisors LLC (5.3%), Driehaus Capital Management LLC (5.1%).
- Are Definium Therapeutics, Inc. insiders buying or selling?
- 14 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Definium Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.